These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1260374)

  • 41. [High performance liquid chromatographic determination of sennoside A in maren pills].
    Zhang Q; Wang B
    Zhongguo Zhong Yao Za Zhi; 1995 Jul; 20(7):413-5, 448. PubMed ID: 7576140
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of a highly purified senna extract on colonic epithelium.
    van Gorkom BA; Karrenbeld A; van Der Sluis T; Koudstaal J; de Vries EG; Kleibeuker JH
    Digestion; 2000; 61(2):113-20. PubMed ID: 10705175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral laxatives in barium enema preparation.
    Ennis JT; Mitchell AV
    Br J Radiol; 1970 Apr; 43(508):242-4. PubMed ID: 4909956
    [No Abstract]   [Full Text] [Related]  

  • 44. [Morphology of inflammatory colonic diseases].
    Borchard F
    Med Welt; 1979 Nov; 30(47):1753-9. PubMed ID: 390295
    [No Abstract]   [Full Text] [Related]  

  • 45. Possible role of laxatives in analgesic nephropathy.
    Wainscoat JS; Finn R
    Br Med J; 1974 Dec; 4(5946):697-8. PubMed ID: 4441864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of the comparative effectiveness of Dulcolax, Laxadine, Dorbanex, Normacen and Senokot laxatives in the bowel preparation of patients for radiological examinations.
    Obisesan AA; Osinaike I
    Niger Med J; 1978 Nov; 8(6):563-70. PubMed ID: 753059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colonic preparation: a controlled trial of Dulcodos, Dulcolax and Senokot DX.
    Sanders RC; Wright FW
    Br J Radiol; 1970 Apr; 43(508):245-7. PubMed ID: 4909957
    [No Abstract]   [Full Text] [Related]  

  • 48. Possible hepatotoxicity of Doxidan.
    Tolman KG; Hammar S; Sannella JJ
    Ann Intern Med; 1976 Mar; 84(3):290-2. PubMed ID: 1259264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Danthron prohibition].
    Ippen H
    Dtsch Med Wochenschr; 1987 Apr; 112(14):569-70. PubMed ID: 3829944
    [No Abstract]   [Full Text] [Related]  

  • 50. Laxative eruption.
    Verbov J
    Clin Exp Dermatol; 1984 Jul; 9(4):435. PubMed ID: 6235067
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical and toxicological aspects of anthraquinone laxatives.
    Nelemans FA
    Pharmacology; 1976; 14 Suppl 1():73-7. PubMed ID: 981318
    [No Abstract]   [Full Text] [Related]  

  • 52. [A comparative study of various new methods for the determination of sennosides in Senna leaf and Senna fruit].
    van Os FH; Zwaving JH; Richters AR
    Pharm Weekbl; 1968 Mar; 103(13):317-32. PubMed ID: 5654424
    [No Abstract]   [Full Text] [Related]  

  • 53. Danthron.
    National Toxicology Program
    Rep Carcinog; 2011; 12():128-9. PubMed ID: 21850139
    [No Abstract]   [Full Text] [Related]  

  • 54. [Measurement of the intestinal clearance of alpha 1-antitrypsin and the exchangeable potassium pool in elderly patients treated with anthraquinone glycosides].
    Emeriau JP; Manciet G; Borde C; Raynal F; Galley P
    Gastroenterol Clin Biol; 1983 Oct; 7(10):799-801. PubMed ID: 6605271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effectiveness of X-Prep as a bowel evacuant prior to roentgenography of the gastrointestinal tract.
    STATMAN AJ
    Am J Gastroenterol; 1960 Jun; 33():740-2. PubMed ID: 13833895
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term mucosal alterations by sennosides and related compounds.
    Dufour P; Gendre P
    Pharmacology; 1988; 36 Suppl 1():194-202. PubMed ID: 3368519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of the effectiveness and tolerability of the saccharosum-sennosid-B solution and sodium-picosulfate in preparation for colonoscopy. Prospective, multicenter, randomized study].
    Demeter P; Ujszászy L; Sike R; Tóth GT; Grenda A; Kiss GG; Novák J; Gurzó Z; Csiki Z
    Orv Hetil; 2003 Aug; 144(32):1587-90. PubMed ID: 12974184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Danthron alarm, FDA response: crucial OTC drug control.
    Gilbertson WE; Lessing M
    Mil Med; 1988 Sep; 153(9):487-8. PubMed ID: 3141843
    [No Abstract]   [Full Text] [Related]  

  • 59. [Perianal skin changes caused by anthraquinone in laxatives].
    Bergström G; Holst R
    Lakartidningen; 1972 Oct; 69():Suppl 3:28-9. PubMed ID: 4264668
    [No Abstract]   [Full Text] [Related]  

  • 60. Laxative eruption in napkin area.
    Verbov J
    Practitioner; 1979 Jul; 223(1333):108. PubMed ID: 482238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.